glp-1 gip news ๐จ Big for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in Don't miss "In the News"
Description
Intended for research purposes only
#retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor
Consultancy sees the active GLP-1 user population rising by as much as 50% by 2027.
Medications from these distinct classes of pharmaceutical agents may be used as treatment by themselves (monotherapy) or in a combination of 2 or more drugs from multiple classes with different mechanisms of action
